These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 11402315)

  • 41. A central role for the JNK pathway in mediating the antagonistic activity of pro-inflammatory cytokines against transforming growth factor-beta-driven SMAD3/4-specific gene expression.
    Verrecchia F; Tacheau C; Wagner EF; Mauviel A
    J Biol Chem; 2003 Jan; 278(3):1585-93. PubMed ID: 12426318
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of TGF-beta/Smad signaling pathway on lung myofibroblast differentiation.
    Gu L; Zhu YJ; Yang X; Guo ZJ; Xu WB; Tian XL
    Acta Pharmacol Sin; 2007 Mar; 28(3):382-91. PubMed ID: 17303001
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Halofuginone inhibition of COL1A2 promoter activity via a c-Jun-dependent mechanism.
    McGaha TL; Kodera T; Spiera H; Stan AC; Pines M; Bona CA
    Arthritis Rheum; 2002 Oct; 46(10):2748-61. PubMed ID: 12384935
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Smad3 interacts with JunB and Cbfa1/Runx2 for transforming growth factor-beta1-stimulated collagenase-3 expression in human breast cancer cells.
    Selvamurugan N; Kwok S; Partridge NC
    J Biol Chem; 2004 Jun; 279(26):27764-73. PubMed ID: 15084595
    [TBL] [Abstract][Full Text] [Related]  

  • 45. JunB suppresses cell proliferation by transcriptional activation of p16(INK4a) expression.
    Passegué E; Wagner EF
    EMBO J; 2000 Jun; 19(12):2969-79. PubMed ID: 10856241
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type beta transforming growth factor.
    Xu W; Angelis K; Danielpour D; Haddad MM; Bischof O; Campisi J; Stavnezer E; Medrano EE
    Proc Natl Acad Sci U S A; 2000 May; 97(11):5924-9. PubMed ID: 10811875
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Constitutive expression of the AP-1 transcription factors c-jun, junD, junB, and c-fos and the marginal zone B-cell transcription factor Notch2 in splenic marginal zone lymphoma.
    Trøen G; Nygaard V; Jenssen TK; Ikonomou IM; Tierens A; Matutes E; Gruszka-Westwood A; Catovsky D; Myklebost O; Lauritzsen G; Hovig E; Delabie J
    J Mol Diagn; 2004 Nov; 6(4):297-307. PubMed ID: 15507668
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A new group of conserved coactivators that increase the specificity of AP-1 transcription factors.
    Claret FX; Hibi M; Dhut S; Toda T; Karin M
    Nature; 1996 Oct; 383(6599):453-7. PubMed ID: 8837781
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential inhibition of UVB-induced AP-1 and NF-kappaB transactivation by components of the jun bZIP domain.
    Cooper S; Ranger-Moore J; Bowden TG
    Mol Carcinog; 2005 Jun; 43(2):108-16. PubMed ID: 15791649
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential regulation of JunB and JunD by adenovirus type 5 and 12 E1A proteins.
    de Groot RP; Meijer I; van den Brink S; Mummery C; Kruijer W
    Oncogene; 1991 Dec; 6(12):2357-61. PubMed ID: 1837351
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Embryonic stem (ES) cells lacking functional c-jun: consequences for growth and differentiation, AP-1 activity and tumorigenicity.
    Hilberg F; Wagner EF
    Oncogene; 1992 Dec; 7(12):2371-80. PubMed ID: 1281302
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Overexpression of members of the AP-1 transcriptional factor family from an early stage of renal carcinogenesis and inhibition of cell growth by AP-1 gene antisense oligonucleotides in the Tsc2 gene mutant (Eker) rat model.
    Urakami S; Tsuchiya H; Orimoto K; Kobayashi T; Igawa M; Hino O
    Biochem Biophys Res Commun; 1997 Dec; 241(1):24-30. PubMed ID: 9405228
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Coactivation of AP-1 activity and TGF-beta1 gene expression in the stress response of normal skin cells to ionizing radiation.
    Martin M; Vozenin MC; Gault N; Crechet F; Pfarr CM; Lefaix JL
    Oncogene; 1997 Aug; 15(8):981-9. PubMed ID: 9285693
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Specific interactions between Smad proteins and AP-1 components determine TGFβ-induced breast cancer cell invasion.
    Sundqvist A; Zieba A; Vasilaki E; Herrera Hidalgo C; Söderberg O; Koinuma D; Miyazono K; Heldin CH; Landegren U; Ten Dijke P; van Dam H
    Oncogene; 2013 Aug; 32(31):3606-15. PubMed ID: 22926518
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response.
    Ashcroft GS; Yang X; Glick AB; Weinstein M; Letterio JL; Mizel DE; Anzano M; Greenwell-Wild T; Wahl SM; Deng C; Roberts AB
    Nat Cell Biol; 1999 Sep; 1(5):260-6. PubMed ID: 10559937
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structural and functional characterization of the transforming growth factor-beta -induced Smad3/c-Jun transcriptional cooperativity.
    Qing J; Zhang Y; Derynck R
    J Biol Chem; 2000 Dec; 275(49):38802-12. PubMed ID: 10995748
    [TBL] [Abstract][Full Text] [Related]  

  • 57. c-Jun inhibits transforming growth factor beta-mediated transcription by repressing Smad3 transcriptional activity.
    Dennler S; Prunier C; Ferrand N; Gauthier JM; Atfi A
    J Biol Chem; 2000 Sep; 275(37):28858-65. PubMed ID: 10871633
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proximal promoter region of the junB gene mediates attenuation of serum inducibility in Src-transformed cells.
    Yu CL; Prochownik EV; Jove R
    Cell Growth Differ; 1995 Dec; 6(12):1513-21. PubMed ID: 9019156
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activator protein 1 transcription factors are fundamental to v-rasHa-induced changes in gene expression in neoplastic keratinocytes.
    Rutberg SE; Adams TL; Glick A; Bonovich MT; Vinson C; Yuspa SH
    Cancer Res; 2000 Nov; 60(22):6332-8. PubMed ID: 11103794
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The hepatitis B virus preS2/St transactivator utilizes AP-1 and other transcription factors for transactivation.
    Lauer U; Weiss L; Lipp M; Hofschneider PH; Kekulé AS
    Hepatology; 1994 Jan; 19(1):23-31. PubMed ID: 8276360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.